Increased testing levels reflect changing demand and the onboarding of new safeCircle clients, Subcontractor Award for Community-based Pop-Up Testing Service. FQ1’22 testing levels are up over 90% compared to FQ4’21, and FQ2’22 testing levels are up much more.
Applied DNA Sciences, Inc., a leader in PCR-based DNA manufacturing and nucleic acid-based technologies announced on Tuesday that COVID-19 testing levels increased by more than 90% (unaudited) for the fiscal quarter ended December 31, 2021, compared to the fiscal quarter ended September 30, 2021, at its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs (ADCL). Since the quarter ended December 31, 2021, ADCL has seen a further strengthening of demand. The surge in demand is attributed to current safeCircleTM clients looking to securely reopen or expand operations at municipalities, campuses, and enterprises, as well as the onboarding of new clients, according to ADCL.
The safeCircle program from ADCL is a fully integrated testing platform for enterprise and educational institutions that includes sample collection, test site infrastructure design and management, results tracking, and immunization status management.
“Our approach to COVID-19 testing remains strategic whereby we are focused on market segments in which we expect testing to be longer-lived. We have proved the safeCircle platform in our operating area and are moving to deploy it nationally with the imminent filing of a request for EUA to the FDA for our Linea™ 2.0 COVID-19 Assay and an associated unsupervised, at-home sample collection kit,”Dr. James A. Hayward, president, and CEO of Applied DNA stated.
Enterprises are setting up monitored COVID-19 testing methods to prevent impacts and other risks to business continuity, as well as to plan for further development of the COVID-19 pandemic and its various scenarios, which has enhanced safeCircle’s sales chances.
In addition, ADCL reported that it has been awarded a testing subcontract to handle a municipal COVID-19 testing agreement. ADCL is assessing COVID-19 samples submitted by numerous community-based pop-up collecting sites as part of the testing subcontract.